Bristol Myers Squibb

bms.com · New York City, United States of America

Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and commercializes prescription medicines for oncology, hematology, immunology, cardiovascular, and other serious diseases. It serves patients worldwide through hospital systems, physicians, and pharmacies, generating revenue from the sale of branded pharmaceutical products and related therapies.

Revenue
$1B+
Employees
5,001+
Founded
1887
Headquarters
New York City, United States of America

Bristol Myers Squibb customers on Arbolus

Total customers 13 13 current · 0 former
Reviews growth 7 new reviews since Jun 2026

Customers who reviewed Bristol Myers Squibb

Seniority of Bristol Myers Squibb customers

The largest group of people who reviewed Bristol Myers Squibb holds C-Suite roles (46%), followed by Director (31%) and Manager (23%).

  • C-Suite 46%
  • Director 31%
  • Manager 23%

Customers sample

Revenue Leader Director NPS 8 Undecided
Generalist Generalist C-Suite NPS 4 Not renewing
Revenue Leader Director NPS 9

Employer names and spend open once the report publishes.

What 13 Arbolus experts think of Bristol Myers Squibb

Overall sentiment: Positive

The NPS distribution is heavily weighted towards the positive with 4 responses at 9+ and a majority at 8 or higher. Renewal intent is strong among established, high-spend customers, but a notable proportion (about 36%) report being unsure or not renewing, often in pilot or offboarding stages. Adoption is highest among customers with more than 1 year of implementation and high spend levels. Sentiment is therefore positive, anchored by strong loyalty in mature deployments, though early or pilot users show more mixed intentions.

Tell us when the Bristol Myers Squibb report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

0 Net Promoter Score, from 13 scored reviews
  • Promoters 4
  • Passives 5
  • Detractors 4

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 4
  • Undecided 4
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 60% 5 answers
  • Director 0% 3 answers
  • Manager 50% 2 answers
  • 8/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers
  • 4/10 Average score from customers not renewing

Top alternatives

Most weighed by Bristol Myers Squibb customers

For people who use Bristol Myers Squibb

Do you use Bristol Myers Squibb at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of Bristol Myers Squibb have already contributed

Takes a few minutes. Your identity stays anonymous.